NCT05624918 2026-04-08
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Big Ten Cancer Research Consortium
Phase 2 Recruiting
Clinical Trials
7 trialsNCT03384238 2026-03-17
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Stanford University
Phase 1/2 Recruiting
NCT06095141 2025-08-07
PTCA199-6
Fudan University
Phase 2/3 Recruiting
NCT06149689 2025-08-07
PTCA199-7
Fudan University
Phase 2 Recruiting
NCT06250972 2025-08-07
PTCA199-11
Fudan University
Phase 3 Recruiting
NCT06789679 2025-01-30
Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT05268692 2022-03-07
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Kochi University
Phase 2/3 Recruiting